Search results for '**' (418 products)

Showing 1-10 of 418

11 May 2020  |  Asia Pacific

Outlook of India’s Healthcare Industry, 2020

Indian Healthcare Industry is Expected to Grow at 16.9% in 2020 to Reach $272.79 Billion in 2020

The study covers the healthcare market which develops and provides products, solutions, and/or services across the care spectrum for diagnosis, treatment, and prevention. The biosimilars market in India is expected to cross $0.9 billion by 2020. The growing prevalence of chronic diseases with an increasing aged population in India and globally, c...

USD 4,950.00
30 Apr 2020  |  Asia Pacific

COVID-19—Implications for the Healthcare Industry, 2020

Winning Strategies and Key Opportunities that are Evolving During this Disruption

A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...

USD 4,950.00
14 Feb 2020  |  Asia Pacific

Select Diagnostic Imaging Equipment Market Landscape in Malaysia, Forecast to 2023

New Budget Allocations, Expansions in Private Sector, and Time to Market on Next-generation Imaging Equipment Opens Up Robust Market Opportunities

This study presents an analysis of the Malaysian diagnostic imaging equipment market. It provides an in-depth analysis of the current trends, market size, and revenue forecast, and market penetration, market attractiveness, in digital radiography, ultrasound, computed tomography, magnetic resonance imaging, interventional X-ray, and fluoroscopy. M...

USD 4,950.00
07 Feb 2020  |  Asia Pacific

Thai Diabetes Devices Market, Forecast to 2023

The Professional Testing Segment will See a High Growth Rate of 10% in this High-cost Device Market

Diabetes is a growing global concern, with more than 425 million people suffering the world over. Thailand is no exception. It has a high prevalence of about 8%; there were an estimated 4.25 million diabetics in the country in 2018. Unfortunately, only about 56% of this population is actually diagnosed, meaning almost half of those diabetics are di...

USD 3,000.00
07 Feb 2020  |  Asia Pacific

Malaysian Diabetes Devices Market, Forecast to 2023

Service Models that Address Affordability are the Preferred Models in this Cost-sensitive Market

Diabetes is a growing concern globally, with more than 425 million people suffering the world over. Malaysia is no exception. It has a very high prevalence of about 16%; there were an estimated 3.57 million diabetics in the country in 2018. Unfortunately, only about 50% of this population is actually diagnosed, meaning half of those diabetics are d...

USD 3,000.00
06 Feb 2020  |  Asia Pacific

Philippine Diabetes Devices Market, Forecast to 2023

Universal Healthcare Coverage will Help Boost the Low Diagnosis Rate of 33% and Unlock Market Potential

Diabetes is a growing concern globally, with more than 425 million people suffering the world over. The Philippines is no exception. It has a high prevalence of diabetes, of about 6% or an estimated 3.8 million diabetics, in 2018. Unfortunately, only about 33% of this population is actually diagnosed, meaning more than two-thirds of those diabetic...

USD 3,000.00
06 Feb 2020  |  Asia Pacific

Indonesian Diabetes Devices Market, Forecast to 2023

Low Diagnosis Rate of 26% Presents Opportunities to Unlock and Tap in to a Large Market

Diabetes is a growing concern, with more than 425 million people suffering the world over. Indonesia is no exception. It has high prevalence, of about 7% or an estimated 10.48 million diabetics in the country in 2018. Unfortunately, only about 26% of this population is actually diagnosed, meaning over two-thirds of those diabetics are diagnosed onl...

USD 3,000.00
10 Jan 2020  |  Asia Pacific

Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025

Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

USD 10,000.00
21 Jun 2019  |  Asia Pacific

Chinese In-vitro Diagnostics Market Insight, Forecast to 2023

The China Manufacturing 2025 Program for Promoting Local R&D Investments and Increasing Demand from Tier I and II Hospitals Set to Transform the Industry Landscape

The In-vitro Diagnostics (IVD) market in China shows strong growth potential in several segments. Market growth is set to be driven by the growing volume of tests, rather than the higher price of testing solutions in traditional segments and the popularization of advanced testing technology in emerging segments. In the context of the reform in publ...

USD 1,500.00

USD 1,350.00 save 10 %

17 Jun 2019  |  Asia Pacific

Regulatory Trends in Select Asian Bone Mineral Density Solutions, 2017

Unchanged Regulatory Process for DXA-BMD Device Approval Makes it Easier for Market Adoption

This study carries Frost & Sullivan’s observation of bone mineral density solutions in select Asian Countries (Australia, South Korea, and China); the regulatory trends for the same have been covered, highlighting the following: • Product registration and regulatory approval process details in select Asian countries (such as the Therapeutic Goo...

USD 1,500.00

USD 1,350.00 save 10 %

Showing 1-10 of 418